HealthMatch: Funding, Investors & Team (Sep 2026)

HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives. We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow. For clinicians and patients, there is a real struggle to identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials. With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.

HealthMatch has raised $24.9M across 2 rounds on record. The most recent is a Series C of $6.9M announced in Sep 2022.

HealthMatch's most recent funding round on record is a Series C of $6.9M, announced in Sep 2022.

Manuri Gunawardena is listed as CEO at HealthMatch.

HealthMatch is based in Sydney, New South Wales, Australia.

HealthMatch is in the 11-50 employee band.

HealthMatch's latest round of $6.9M is above the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.